Physiology Flashcards
(75 cards)
Coombs test
antoglobulin testing
aetiology of positive Coombs test
haemolytic anaemia
haemolytic transfusion reactions
haemolytic disease of newborn
indirect antiglobulin testing (IAT)
+ uses
detects antibodies present in the patient’s plasma
can be used in cross-matching or to detect maternal anti-D IgG
coagulation
formation of a blood clot.
Essential to Haemostasis
Process is characterised by a cascade of events which lead to formation of a blood clot.
Pathways of coagulation
Extrinsic: triggered by trauma which causes blood to escape circulation
Intrinsic: triggered by internal damage to vessel all
extrinsic pathway- clotting factors
VII, III TF-VIIa complex X -> Xa Va Thrombin (XIII)
extrinsic pathway of clotting
Damage to blood vessel - > Factor VII exits the circulation into surrounding tissues.
Tissue factor (III) is released by damaged cells outside the circulation
Factor VII and III form TF-VIIa complex
TF-VIIa then activates factor X into active Factor Xa
Xa+ Va trigger formation of thrombin
Responsible for initial generation of activated Factor X
intrinsic pathway- clotting factors
XII VIII IX + VIII -> Enzyme complex Factor X activated Factor Va
intrinsic pathway
Factor XII activated when it comes into contact with negatively charge collagen on the damaged endothelium, triggering cascade.
Along with clotting factors, platelets form a cellular ‘Plug’ at site of injury.
Platelets also release mediators that facilitate further clotting, including factor VIII.
Factor IX combines with Factor VIII to form enzyme complex that activates factor X, which along with factor Va, stimulates production of thrombin
Common pathway of clotting
intrinsic and extrinsic pathways converge.
Activated factor X -> inactive enzyme prothrombin (II) converted to its active form thrombin (IIa) by prothrombinase
Thrombin then converts soluble fibrinogens into insoluble fibrin strands.
Fibrin strands are further stabilised by factor XIII
regulation of clotting
Negative feedback on coagulation cascade
- Protein C and protein S
Antithrombin
protease inhibitor that degrades thrombin, factor IXa, factor Xa, factor XIa and factor XIIa
Constantly active, but can be activated further by heparins
protein S
activated following contact by thrombomodulin (activated by thrombin)
Along with co-factors (including protein S), activated protein C degrades factor V and factor VIIa, thus slowing rate of clotting.
protein C deficiency
Inherited or acquired (sepsis & liver disease)
Due to reduction in protein C, clotting cascade is under less inhibition.
patient care pre-disposed to abnormal and excessive clotting, leading to illnesses including DVT and stroke
fibrinolysis
fibrin is dissolved - leading to consequent dissolution of the clot.
Endothelial cells of blood vessel wall secrete tissue plasminogen activators (tPA) which convert precursor plasminogen to plasmin.
Plasmin then cleaves fibrin within the thrombus.
haemophilia
inherited bleeding disorder caused by partial or total deficiency in specific clotting factors.
Haemophilia A
deficiency in factor VIII
Haemophilia B
deficiency in factor IX
Haemophilia C
deficiency in factor XI
presentation of haemophilia
bruise easily.
Bleed spontaneously
Bleed for longer
haematopoiesis
production of cells that circulate in the bloodstream.
erythropoiesis
process by which RBCs are produced
sites of erythropoiesis
very early foetus: yolk sac
2-5 months gestation: liver and spleen
5 months gestation; bone marrow
Children- bone marrow of most bones
Adults- bone marrow of vertebrae, ribs, sternum, sacrum, pelvic and proximal femur
inadequate erythropoiesis in bone marrow
can trigger extra medullary hematopoiesis
commonly seen in haemoglobinopathies (thalassaemia’s and myelofibrosis